How BRCA and Other Gene Changes Influence Multiple Myeloma Risk, Treatment, and Your Family's Health
Event Description
Are changes in the BRCA genes linked to Multiple Myeloma? If so, how can these changes impact your risk, treatment options, and family health. Dr. Santiago Thibaud will join us to discuss recent research in Pathogenic Germline Variants. Learn why genetic testing is becoming an important tool in understanding multiple myeloma, and how these findings can influence treatment plans, improve outcomes, and help identify cancer risks for you and your family.
Schedule & Agenda
Cynthia introduces the agenda of the event and featured speaker Dr. Santiago Thibaud
Cynthia introduces the agenda of the event and featured speaker Dr. Santiago Thibaud
Dr. Santiago Thibaud discusses why genetic testing is becoming an important tool in understanding multiple myeloma, and how these findings can influence treatment plans, improve outcomes, and help identify cancer risks for you and your family.
Dr. Santiago Thibaud discusses why genetic testing is becoming an important tool in understanding multiple myeloma, and how these findings can influence treatment plans, improve outcomes, and help identify cancer risks for you and your family.
Type your questions in the chat and we will answer them!
Type your questions in the chat and we will answer them!
Speakers & Moderators
Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.
Santiago Thibaud, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai and a member of the physician team at the Center of Excellence for Multiple Myeloma. Dr. Thibaud earned his MD from Centro de Educación Médica e Investigaciones Clínicas in Buenos Aires, Argentina. He completed Internal Medicine residency at Albert Einstein College of Medicine/Montefiore Medical Center, where he also served as Chief Resident. Dr. Thibaud did his fellowship training in Hematology and Medical Oncology at the Icahn Mount Sinai. He received the Young Investigator Award for Exemplary Abstract at the 2021 International Myeloma Workshop and First Prize for Oral Presentation at Icahn Mount Sinai’s Annual Research Day in 2021. Dr. Thibaud has a special interest in monitoring long-term patients and attending to conditions that may result from prior treatment.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Your Source for Expert Insights & Support in Multiple Myeloma.
By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.